These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 8090027

  • 1. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Chiu EK, Chan LC, Liang R, Lie A, Kwong YL, Todd D, Chan TK.
    Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027
    [Abstract] [Full Text] [Related]

  • 2. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group.
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [Abstract] [Full Text] [Related]

  • 3. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [Abstract] [Full Text] [Related]

  • 4. Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
    Hoelzer D, Thiel E, Ludwig WD, Löffler H, Büchner T, Freund M, Heil G, Hiddemann W, Maschmeyer G, Völkers B.
    Leukemia; 1993 Aug; 7 Suppl 2():S130-4. PubMed ID: 8361217
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Ribera JM, Oriol A, Sanz MA, Tormo M, Fernández-Abellán P, del Potro E, Abella E, Bueno J, Parody R, Bastida P, Grande C, Heras I, Bethencourt C, Feliu E, Ortega JJ.
    J Clin Oncol; 2008 Apr 10; 26(11):1843-9. PubMed ID: 18398150
    [Abstract] [Full Text] [Related]

  • 6. [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Ribera JM, Grañena A, Rozman C, Urbano-Ispizua A, Bladé J, Carreras E, Cervantes F, Marín P, Sierra J, Nomdedeu B.
    Sangre (Barc); 1990 Feb 10; 35(1):26-32. PubMed ID: 2333581
    [Abstract] [Full Text] [Related]

  • 7. Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group.
    Brandalise S, Odone V, Pereira W, Andrea M, Zanichelli M, Aranega V.
    Leukemia; 1993 Aug 10; 7 Suppl 2():S142-5. PubMed ID: 8361220
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, van 't Veer MB, Rammeloo JA, de Koning J, van Zanen GE.
    Am J Pediatr Hematol Oncol; 1989 Aug 10; 11(2):125-33. PubMed ID: 2665546
    [Abstract] [Full Text] [Related]

  • 9. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A, Ishii E, Okamura J, Eguchi H, Yoshida N, Yanai F, Inoue T, Miyake K, Ishihara T, Tsuboi C.
    Med Pediatr Oncol; 1996 Jan 10; 26(1):10-9. PubMed ID: 7494507
    [Abstract] [Full Text] [Related]

  • 10. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E, Eguchi H, Matsuzaki A, Koga H, Yanai F, Kuroda H, Kawakami K, Ayukawa H, Akiyoshi K, Kamizono J, Tamai Y, Kinukawa N, Okamura J.
    Med Pediatr Oncol; 2001 Jul 10; 37(1):10-9. PubMed ID: 11466717
    [Abstract] [Full Text] [Related]

  • 11. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR.
    Blood; 1995 Apr 15; 85(8):2025-37. PubMed ID: 7718875
    [Abstract] [Full Text] [Related]

  • 12. [Clinical trial of protocol-AL851 for children with high-risk acute lymphoblastic leukemia. Kyushu Yamaguchi Children's Cancer Study Group (KYCCSG)].
    Matsuzaki A, Ishii E, Ueda K, Yanai F, Nibu K, Take H, Koga H, Miyazaki S, Inoue T, Miyake K.
    Rinsho Ketsueki; 1994 Sep 15; 35(9):862-70. PubMed ID: 7967055
    [Abstract] [Full Text] [Related]

  • 13. Acute lymphoblastic leukemia in the elderly: results of two different treatment approaches in 49 patients during a 25-year period.
    Ferrari A, Annino L, Crescenzi S, Romani C, Mandelli F.
    Leukemia; 1995 Oct 15; 9(10):1643-7. PubMed ID: 7564503
    [Abstract] [Full Text] [Related]

  • 14. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.
    Linker C, Damon L, Ries C, Navarro W.
    J Clin Oncol; 2002 May 15; 20(10):2464-71. PubMed ID: 12011123
    [Abstract] [Full Text] [Related]

  • 15. An update of the results of intensive therapy in children with acute lymphoblastic leukemia.
    Pavlovsky S, Sackmann Muriel F, Santarelli MT, Svarch E, Jiménez E, Kohan R, Rosso A.
    Leukemia; 1992 May 15; 6 Suppl 2():167-70. PubMed ID: 1578923
    [Abstract] [Full Text] [Related]

  • 16. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
    Paolucci G, Vecchi V, Favre C, Miniero R, Madon E, Pession A, Rondelli R, De Rossi G, Lo Nigro L, Porta F, Santoro N, Indolfi P, Basso G, Conter V, Aricò M, Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
    Haematologica; 2001 May 15; 86(5):478-84. PubMed ID: 11410410
    [Abstract] [Full Text] [Related]

  • 17. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD, Wolff SN, Stein RS, Greer JP, Cousar JB, Greco FA.
    Cancer Treat Rep; 1986 Aug 15; 70(8):953-8. PubMed ID: 3015406
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].
    Doubek M, Mayer J, Korístek Z, Protivánková M, Brychtová Y, Oborilová A, Král Z, Klabusay M, Tomíska M, Buchtová I, Vorlícek J.
    Cas Lek Cesk; 2002 Mar 01; 141(4):122-6. PubMed ID: 12046256
    [Abstract] [Full Text] [Related]

  • 19. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ, Blatt J, Sather HN, Meadows AT.
    Med Pediatr Oncol; 1996 Jul 01; 27(1):15-20. PubMed ID: 8614385
    [Abstract] [Full Text] [Related]

  • 20. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Marshall GM, Dalla Pozza L, Sutton R, Ng A, de Groot-Kruseman HA, van der Velden VH, Venn NC, van den Berg H, de Bont ES, Maarten Egeler R, Hoogerbrugge PM, Kaspers GJ, Bierings MB, van der Schoot E, van Dongen J, Law T, Cross S, Mueller H, de Haas V, Haber M, Révész T, Alvaro F, Suppiah R, Norris MD, Pieters R.
    Leukemia; 2013 Jul 01; 27(7):1497-503. PubMed ID: 23407458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.